CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
ASSETS
Cash and due from banks	$ 25,816	$ 24,139
Federal funds sold and interest bearing deposits in banks	21,274	6,520
Cash and cash equivalents (Note 3)	47,090	30,659
Securities available for sale, at fair value (Note 5)	215,290	203,763
Restricted stock	5,741	5,741
Loans held for sale	2,110	7,634
Loans:
Portfolio loans (Note 6)	891,300	882,548
Allowance for loan losses (Note 6)	(17,791)	(17,637)
Net loans	873,509	864,911
Bank premises and equipment, net	8,322	8,721
Other real estate owned	951	1,366
Bank owned life insurance	19,122	18,611
Goodwill, net (Note 4)	21,582	21,582
Intangible assets, net (Note 4)	492	594
Accrued interest receivable	3,750	3,726
Other assets	12,543	10,946
Total Assets	1,210,502	1,178,254
Deposits: (Note 7)
Demand and other noninterest-bearing	139,871	139,894
Savings, money market and interest-bearing demand	391,558	377,287
Time deposits	500,816	482,411
Total deposits	1,032,245	999,592
Short-term borrowings (Note 8)	1,643	1,115
Federal Home Loan Bank advances (Note 9)	46,658	46,508
Junior subordinated debentures (Note 10)	16,238	16,238
Accrued interest payable	804	882
Accrued expenses and other liabilities	4,953	3,775
Total Liabilities	1,102,541	1,068,110
Shareholders’ Equity
Discount on Series B preferred stock	(25)	(65)
Common stock, par value $1 per share, authorized 15,000,000 shares, issued 9,631,896 shares at September 30, 2013 and 8,272,548 at December 31, 2012	9,632	8,273
Additional paid-in capital	47,740	39,141
Retained earnings	52,474	48,767
Accumulated other comprehensive income (loss)	(4,915)	1,240
Treasury shares at cost, 328,194 shares at September 30, 2013 and at December 31, 2012	(6,092)	(6,092)
Total Shareholders’ Equity	107,961	110,144
Total Liabilities and Shareholders’ Equity	1,210,502	1,178,254
Preferred stock, Series A Voting, no par value, authorized 150,000 shares, none issued at September 30, 2013 and December 31, 2012.
Shareholders’ Equity
Preferred stock	0	0
Fixed rate cumulative preferred stock, Series B, no par value, $1,000 liquidation value, 9,147 shares authorized and issued at September 30, 2013 and 18,880 shares authorized and issued at December 31, 2012
Shareholders’ Equity
Preferred stock	$ 9,147	$ 18,880